Cancer clinical trials in the region Île-de-France
501 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
EGFR
None
Chemotherapy
Radiotherapy
AstraZeneca
Early Access
Lymphoma
B cell lymphoma
Large B cell lymphoma
2
3 or more
Systemic Treatment-Naive
Hoffmann-La Roche
Early Access
Lung cancer
SCLC (Small Cell Lung Cancer)
Localized
Locally Advanced
None
Chemotherapy
Radiotherapy
Chemotherapy
Radiotherapy
AstraZeneca
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
None
Systemic Treatment-Naive
Janssen
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
1
Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access
Lymphoma
B cell lymphoma
Large B cell lymphoma
1
Systemic Treatment-Naive
Hoffmann-La Roche
Phase 3
Breast cancer
#NCT07237256
#2025-520979-13-00
HER2 Negative
HR Positive
Localized
None
Systemic Treatment-Naive
Surgery
Chemotherapy
Targeted therapy
Institut Curie (Saint Cloud) - Hôpital René Huguenin (Saint-Cloud)
UNICANCER
Phase 3
Prostate cancer
#NCT06925737
#2024-517423-40-00
Adenocarcinoma
Metastatic Castration-resistant
1
2
Targeted therapy
Hormone therapy
Systemic Treatment-Naive
Chemotherapy
Hôpital Saint Louis AP-HP (Paris), Hôpital Foch (Suresnes)
Merck Sharp & Dohme LLC
Phase 3
Lung cancer
#NCT06119581
#2023-503412-33-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
KRAS G12C
None
Systemic Treatment-Naive
BRAF
EGFR
HER2
MET
NTRK-1/2/3
RET
ROS-1
Immunotherapy
Chemotherapy
Targeted therapy
Gustave Roussy (Villejuif), Institut Curie - Paris (Paris), Hôpital Foch (Suresnes)
Eli Lilly et compagnie
Phase 3
Lung cancer
#NCT06881784
#2024-518154-16-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
Other KRAS
HRAS
KRAS G12C
KRAS non G12C
KRAS G12D
NRAS
1
2
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Gustave Roussy (Villejuif), Hôpital Bichat - Claude Bernard - AP-HP (Paris)
Revolution Medicines, Inc.